Transaction · 0002110603-26-000013

Cain Wettan Keeley M

Cain Wettan Keeley M, EGC, LEGAL, COMP, reported a transaction classified as exercise at GILEAD SCIENCES, INC. involving 590.000000 shares. Reported holdings after the transaction were 9044.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEGC, LEGAL, COMP
GILDGILEAD SCIENCES, INC.
Trade date
Sep 10, 2026
Filing date
Sep 11, 2026
View on SEC Insider profile
Disclosed valueUnknownShares × reported price
Shares traded590Price unknown
Holdings after9.04kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

GILD price since this filing

Daily closing prices, with the filing date and available return windows
GILD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -5.5%1w ago +5.2%1d ago +1.3%
Returns since7d +4.4%30d +5.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0002110603-26-000013
Common Stock
Transaction date
Sep 10, 2026
Filed Sep 11, 2026, 10:28 PM · 1d delay
Shares
590 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
9,044 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+2 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP Gen Counsel, Legal & Comp

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

  2. F2

    The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Original filing · 0002110603-26-000013
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

GILD